O'Brien MM, Ji L, Shah NN, Rheingold SR, et al. Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621. J Clin Oncol 2022 Jan 10:JCO2101693. doi: 10.1200/JCO.21.01693.
PMID: 35007127